Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia

Octreotide en ·quilotórax secundario a corrección de hernia diafragmática congénita

Main Article Content

John Camacho
Marisol Duque
Diana Arias

Abstract

Chyle effusion in the pleural cavity is a rare situation. It may be acquired (surgical injuries) or congenital (abnormalities of the lymphatic system). Clinical manüestations are varied and depend on the amount of chyle Ioss  (malnutrition, fluid and electrolyte imbalance and immune suppression).  This article reports the case of    a female newborn infant diagnosed with Ieft diaphragmatic hernia who presented postoperative chylothorax. Medica) management included nutritional support and octreotide. Resolution of chylothorax was obtained with no additional surgical treatment.

Downloads

Download data is not yet available.

Article Details

References

1. Rasiah SV, Oeij, Lui k.Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health. 2004 Sep-Oct;40(9- l 0):585-8
2. Altuncu E, Akman I, Kiyan G, Ersu R, Yurdakul Z, Bilgen H, Ozdogan T, Ozek E.Report of three cases: congenital chylothorax and treatment modalities. Turk J Pediatr. 2007 Oct-Dec;49(4):418-2I.
3. Kalomenidis l. Octreotide and chylothorax. CurrOpinPulm Med. 2006 Jul;l2(4):264-7.
4. Paget-Brown A, Kattwinkel J, Rodgers BM, Michalsky MP. The use of octreoti­ de to treat congenital chylothorax. J Pediatr Surg. 2006 Apr;41(4):845-7.
5. Gonzalez R, Bryner BS, Teitelbaum DH, Hirschl RB, Drongowski RA, Mychaliska GB. Chylothoraxafter congenital diaphragmatic hernia repair. J Pediatr Surg. 2009 Jun;44(6):I 181-5.
6. Goyal A, Smith NP, Jesudason EC, Kerr S, Losty PD. Octreotidefor treatment of chylothorax after repair of congenital diaphragmatic hemia.J Pediatr Surg. 2003 Aug;38(8):E l9-20.
7. Büttiker V, Fanconi S, Burger R. Chylothoraxin children:guidelinesfordiagnosis and management. Chest.1999Sep;l 16(3):682-7.
8. Wegner A,Wegner ME, Mitad M. Quilotórax en el período neonatal: caso clínico y revisión de la literatura. Rev. chil. pediatr. 1999 Nov; 70(6): 498-504.
9. CrehuáGaudiza E, Izquierdo Macián I, Fernández Gilino C, Gutiérrez Laso A, Morcillo Sopena F, Vento Torres M. Quilotórax neonatal congénito y posquirúr­ gico revisión y algoritmo diagnóstico-terapeútico. Acta Pediatr Esp. 2006; 64: 276-282.
10. Benítez I, Copons C, Castillo F. Tratamiento del Quilotórax. AnPediatrContin. 2008;6(3): 159-165.
11. CoponsC, Benítez l., Castillo F. Salcedo S. Quilotórax neonatal: etiología, evolu­ ción y respuesta al tratarniento.AnPediatr (Barc). 2008;68(3):224-31.
12. Densupsoontorn NS, Jirapinyo P, Wongarn R, Thamonsiri N, Nana A, Laoha­ prasitiporn D, et al. Management of chylothorax and chylopericardium in pe­ diatric patients: experiences at Siriraj Hospital, Bangkok.Asia Pac J ClinNu­ tr. 2005;14(2):182-7.
13. Milonakis M, Chatzis A, Giannopoulos N, Contrafouris C, Bobos D, Kirvassilis G, et al. Etiology and management of chylothoraxfollowing Pediatric Heart Sur­ gery. J Card Surg. 2009;24:369-373.
14. Efrati O, Barak A. Pleural effusions in the pediatric population. Pediatr Rev. 2002 Dec;23(12):4l7-26.
15. Gershanik J, Jonsson H, Riopel D, Packer R. Dietary Management of Neonatal Chylothorax. Pediatrics. 1974;53;400-403.

Citado por